|Description||BML 111 is a FPR2 (lipoxin A4 receptor) agonist. It inhibits tumor-related angiogenesis and reduces tumor growth in hepatoma H22 cell bearing mice. BML 111 also protects against hemorrhagic shock-induced acute lung injury in rats and attenuates renal ischemia/reperfusion injury.|
|Brife Description||FPR2 agonist|
|Synonyms||BML-111; BML 111; BML111. (5S,6R)-Methyl 5,6,7-trihydroxyheptanoate; methyl (5S,6R)-5,6,7-trihydroxyheptanoate|
MK 0927 is a potential bio-active agent., but no detail information has been published yet.
(-)-catechin gallate, an antioxidant component existing in green tea, has been found to be probably effective in restraining tyrosine phosphorylation caused by ...
Catestatin, a peptide compound, has been found to be a non-competitive nicotinic cholinergic antagonist.
Neuromedin U (rat)
Neuromedin U, a structurally highly conserved neuropeptide, is ubiquitously distributed, with highest levels found in the gastrointestinal tract and pituitary. ...
Ono-4007 sodium salt
The sodium salt form of Ono-4007, a partial analogue of bacterial lipopolysaccharide, has been found to stimulate tumor necrosis factor so that could be useful ...
Glutaminase C-IN-1, with effect to suppresse breast cancer cell growth and invasive activity in vitro, it is an allosteric, cell-permeable and reversible inhibi...
Flutroline is a γ-carboline antipsychotic agent. It is safe and efficient.
Acebutolol is a synthetic butyranilide derivative with hypotensive and antiarrhythmic activity as a beta blocker for the treatment of hypertension and arrhythmi...